Business Description
Revolution Medicines is a clinical-stage biotech company focused on developing targeted treatments for cancers driven by RAS gene mutations, a notoriously difficult group of cancers to treat. The company has built a broad pipeline of drug candidates designed to block the abnormal RAS proteins that fuel tumor growth, either on their own or in combination with other agents that cut off the biological pathways keeping these cancers alive. Several of its lead drugs are already in clinical trials, including one program that has advanced to a late-stage study in pancreatic cancer. Founded in 2014 and based in Redwood City, California, the company is working to bring meaningful new treatment options to patients with few alternatives.
